CRDF Research and Charts

CRDF - Cardiff Oncology Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-05 (Delayed quote data 2025-07-11)

Last 4.07	Change ⇓ -0.09 (-2.16%)	Volume 885,982
	Open 4.10	High 4.24	Low 4.02

8EMA (Daily) 3.85	40EMA (Daily) 3.47	50EMA (Daily) 3.44	STO (Daily) 84.804	MACD Hist (Daily) 0.159
8EMA (Weekly) 3.519	40EMA (Weekly) 3.32	50EMA (Weekly) 3.26	STO (Weekly) 59.028	MACD Hist (Weekly) 0.149


Company Profile
Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.